Inventor · disambiguated record
Hidekazu Toyofuku
Also filed as: TOYOFUKU HIDEKAZU
6 granted patents·12 pending applications·7 citations·filing 2013–2024
74Inventor score
Top patents by PatentIndex Score
18 records- 0186US2025241909A1Injectable formulationOTSUKA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0284US2024277702A1Injectable formulationOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0383US10624889B2Injectable formulationOTSUKA PHARMA CO LTD·Filed 2017·Granted Apr 21, 2020·1 cites·13 claims
- 0482US9499525B2Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2013·Granted Nov 22, 2016·5 cites·12 claims
- 0576US2022305007A1Injectable formulationOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0673US2023049327A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0772US10407415B2Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2016·Granted Sep 10, 2019·1 cites·3 claims
- 0868US2020163960A1Injectable formulationOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0967US2020140424A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1066US2021115030A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1162US2024016937A1Composition containing nucleic acid molecule stablyTORAY INDUSTRIES·Filed 2023·Application pending·0 cites
- 1259US2015086632A1Injectable FormulationOTSUKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 1344US11326163B2Therapeutic agent for fibrosisKYORIN SEIYAKU KK·Filed 2018·Granted May 10, 2022·0 cites·7 claims
- 1438US10337009B2Single-stranded nucleic acid molecule for inhibiting TGF-β1 expressionBONAC CORP·Filed 2015·Granted Jul 2, 2019·0 cites·23 claims
- 1538US2019010503A1Single-stranded nucleic acid molecule inhibiting expression of prorenin gene or prorenin receptor gene, and use thereofUNIV HOKKAIDO NAT UNIV CORP·Filed 2016·Application pending·0 cites
- 1636US10751426B2Composition stably containing single-stranded nucleic acid molecule that suppresses expression of TGF-β1 geneBONAC CORP·Filed 2016·Granted Aug 25, 2020·0 cites·14 claims
- 1735US2018099004A1Therapeutic agent for eye diseaseTAKEUCHI HIROFUMI·Filed 2016·Application pending·0 cites
- 1831US2018036409A1Composition containing nucleic acid molecule stablyBONAC CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hidekazu Toyofuku files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →